Engineering anti-cancer nanovaccine based on antigen cross-presentation

Dendritic cells (DCs) present exogenous antigens on major histocompatibility complex (MHC) class I molecules, thereby activating CD8(+) T cells, contributing to tumor elimination through a mechanism known as antigen cross-presentation. A variety of factors such as maturation state of DCs, co-stimula...

Descripción completa

Detalles Bibliográficos
Autores principales: Warrier, Vaishnavi U., Makandar, Amina I., Garg, Manoj, Sethi, Gautam, Kant, Ravi, Pal, Jayanta K., Yuba, Eiji, Gupta, Rajesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822533/
https://www.ncbi.nlm.nih.gov/pubmed/31652460
http://dx.doi.org/10.1042/BSR20193220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822533/
https://www.ncbi.nlm.nih.gov/pubmed/31652460
http://dx.doi.org/10.1042/BSR20193220

Ejemplares similares